Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Sca-1 is an early-response target of histone deacetylase inhibitors and marks hematopoietic cells with enhanced function
PubMed Similar studies Analyze with GEO2R
Expression data from untreated and valproic acid (VPA) treated CD34+ Hematopoietic Stem Cells (HSCs)
mRNA profiles of four developmentally related hematopoietic cell types (LSK, L-S-K+, Gr1+ and Ter119+) isolated from the BM of B6 and D2 mice
Expression profiles of 7-day cultured HSPCs in the presence or absence of valproic acid and/or lithium
The combination of valproic acid and lithium prevents hematopoietic stem/progenitor cell differentiation.
Effect of valproic acid on hematopoiesis: A functional profiling and cell phenotyping approach
Epigenetic and molecular signatures of cord blood CD34(+) cells treated with histone deacetylase inhibitors
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Expression data from Sca-1 knockout mice
PubMed Full text in PMC Similar studies Analyze with GEO2R
Stem cell antigen-1 deficient mammary tumor
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on